Retina

WAILEA, Hawaii — In this Healio video perspective from Retina 2024, Marion R. Munk, MD, PhD, overviews data investigating multiwavelength photobiomodulation for the treatment of dry age-related macular degeneration.

WAILEA, Hawaii — In this Healio video perspective from Hawaiian Eye/Retina 2024, Jay S. Duker, MD, president and CEO of EyePoint Pharmaceuticals, discusses the phase 2 DAVIO 2 results for EYP-1901 for the treatment of wet AMD.

ROME — A deep learning algorithm developed at University of California, Los Angeles, showed superior performance compared with other algorithms and human graders in detecting early biomarkers of age-related macular degeneration progression.

NEW YORK — In a presentation at OSN New York, Shalesh Kaushal, MD, PhD, explains why he encourages ophthalmologists to consider using vitrectomy to treat vitreous floaters.

ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, Bart Leroy, MD, PhD, speaks about RNA interference technology for the treatment of Leber congenital amaurosis type 10.

ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, Gemmy Cheung, MD, explains how the definition of pachychoroid is evolving with new understanding from imaging studies.

LumiThera submitted a de novo request to the FDA to reclassify the Valeda light delivery system as a Class II device for the treatment of dry age-related macular degeneration, according to a press release.

ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, Bart Leroy, MD, PhD, elucidates complications that may occur following gene therapy with Luxturna.